Equities

Escalon Medical Corp

ESMC:QBB

Escalon Medical Corp

Actions
  • Price (USD)0.175
  • Today's Change0.00 / 0.00%
  • Shares traded5.00k
  • 1 Year change-33.91%
  • Beta-0.2510
Data delayed at least 15 minutes, as of May 29 2024 19:12 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Escalon Medical Corp. operates in the healthcare market, specializing in the development, manufacture, marketing and distribution of medical devices for ophthalmic applications. The Company's A-Scan provides information about the internal structure of the eye by sending a beam of ultrasound along a fixed axis through the eye and displaying the various echoes reflected from the surfaces intersected by the beam. Its B-Scan is primarily a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque. Its UBM is a high-frequency/high-resolution ultrasound device, designed to provide information about the anterior segment of the eye. The Company's pachymeter measures the thickness of the cornea. It distributes two intraocular gas products, C3F8 and SF6, which are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery. The Company also provides surgical packs and AXIS image management system software.

  • Revenue in USD (TTM)11.65m
  • Net income in USD-296.71k
  • Incorporated2001
  • Employees38.00
  • Location
    Escalon Medical Corp435 DEVON PARK ROAD, SUITE 824WAYNE 19087United StatesUSA
  • Phone+1 (610) 688-6830
  • Fax+1 (610) 688-3641
  • Websitehttps://www.escalonmedical.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
SETO Holdings Inc4.96m-652.00k1.00m18.00--0.0911--0.2024-0.056-0.0560.39940.1341.572.658.51---20.703.84-29.075.9552.8352.44-13.153.920.99211.240.3040.0019.015.44-61.23------
Motus GI Holdings Inc327.00k-16.10m1.04m15.00--0.3058--3.18-12.68-12.680.11340.58860.03391.184.9221,800.00-109.80-80.63-182.50-112.32-24.46-44.53-3,239.76-6,160.581.67-13.010.4287---46.1154.7030.81---28.25--
Remedent Inc1.13m-259.38k1.10m16.00--0.2324--0.9743-0.013-0.0130.05650.23670.14743.452.69---3.247.35-5.2012.9365.3864.60-21.9721.200.2033-0.7720.00---33.63-21.70-140.31------
Grapefruit USA Inc34.85k-4.37m1.11m9.00------31.76-0.008-0.0080.00006-0.01010.01211.310.22593,872.22-151.85-268.93-----1,304.65-10.09-12,531.68-408.870.0388-1.50-----83.9677.87-35.68------
SPO Global Inc838.00k-540.00k1.17m2.00------1.39-85.99-85.99131.76-476.561.76-------113.56-305.39----31.1527.31-64.44-384.85---1.45-----17.09-15.1313.03------
Invivo Therapeutics Holdings Corp0.00-9.33m1.24m6.00--0.1387-----3.53-3.530.002.870.00----0.00-81.32-73.69-94.35-85.63------------0.00-------6.01--19.74--
Escalon Medical Corp11.65m-296.71k1.30m38.00--1.26--0.1114-0.0401-0.04011.290.22592.403.757.51306,456.30-1.26-1.76-2.84-3.6744.0744.57-0.5265-0.91140.8927-1.620.1584--13.801.33760.89-17.06-19.85--
Acutus Medical Inc9.55m-9.70m1.32m233.00------0.1382-0.33010.09560.3261-0.13530.12111.141.4640,974.25-12.30-46.76-14.84-56.88-24.07-89.12-101.56-773.492.89-4.641.13--136.3627.03-141.35---35.99--
Nemaura Medical Inc0.00-10.65m1.40m36.00---------0.3787-0.37870.00-0.61690.000.00--0.00-117.49-58.18---131.96-------7,384.830.0305-1.4710.81---84.71---1.85--64.14--
Kelyniam Global Inc517.70k-420.28k1.80m0.00--3.36--3.48-0.0253-0.02530.03120.01790.41357.044.38---33.57---41.79--18.86---81.18--1.26--0.6232---26.47---19.10------
Bone Biologics Corp0.00-6.10m1.83m2.00--0.4592-----23.10-23.100.003.620.00----0.00-114.93-98.31-189.37--------------0.00-------502.76------
Data as of May 29 2024. Currency figures normalised to Escalon Medical Corp's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.